Send me a link:

*Text messaging rates may apply.

 Dow Down 0.11% Nasdaq Up 0.16%

PTC Therapeutics, Inc. (PTCT)

-NasdaqGS
27.45 Up 1.03(3.90%) 9:41AM EDT - Nasdaq Real Time Price
Prev Close:26.42
Open:N/A
Bid:25.00 x 200
Ask:27.71 x 1500
1y Target Est:39.20
Beta:-2.138
Next Earnings Date: 7-Aug-14PTCT Earnings announcement
Day's Range:26.89 - 27.68
52wk Range:13.15 - 34.65
Volume:15,192
Avg Vol (3m):445,420
Market Cap:804.97M
P/E (ttm):N/A
EPS (ttm):-2.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PTCT

Comparison

Symbol% ChgMkt Cap
PTCTUp 3.90%804.97M
SRPTUp 2.11%886.37M
VRTXDown 0.56%20.98B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):21.07
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-3.11
Quarterly EPS Est (Jun-14) :-0.74
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback